NCT01395888 - A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD | Biotech Hunter

Enrollment

260

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 1, 2012

Study Completion Date

August 6, 2012

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Novel Dry Powder Inhaler (NDPI)

fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (NDPI)

DRUG

Tiotropium

• Tiotropium (18 mcg) administered QD via a HandiHaler

Trial Locations (55)

1606

GSK Investigational Site, Fredrikstad

3004

GSK Investigational Site, Drammen

4000

GSK Investigational Site, San Miguel de Tucumán

5017

GSK Investigational Site, Bergen

5400

GSK Investigational Site, San Juan

5500

GSK Investigational Site, Mendoza

10787

GSK Investigational Site, Berlin

10789

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

16470

GSK Investigational Site, Saint-Michel

18009

GSK Investigational Site, Cherkassy

19055

GSK Investigational Site, Schwerin

20354

GSK Investigational Site, Hamburg

21502

GSK Investigational Site, Geesthacht

26013

GSK Investigational Site, Crema

27100

GSK Investigational Site, Pavia

30159

GSK Investigational Site, Hanover

34295

GSK Investigational Site, Montpellier

34376

GSK Investigational Site, Immenhausen

38043

GSK Investigational Site, Grenoble

39112

GSK Investigational Site, Magdeburg

40138

GSK Investigational Site, Bologna

47574

GSK Investigational Site, Goch

51092

GSK Investigational Site, Reims

59000

GSK Investigational Site, Lille

61035

GSK Investigational Site, Kharkiv

62408

GSK Investigational Site, Béthune

70020

GSK Investigational Site, Cassano Murge (BA)

83099

GSK Investigational Site, Donetsk

84025

GSK Investigational Site, Eboli (SA)

98603

GSK Investigational Site, Yalta

105077

GSK Investigational Site, Moscow

115093

GSK Investigational Site, Moscow

150003

GSK Investigational Site, Yaroslavl

150062

GSK Investigational Site, Yaroslavl

153511

GSK Investigational Site, Kokhma

197022

GSK Investigational Site, Saint Petersburg

394018

GSK Investigational Site, Voronezh

410053

GSK Investigational Site, Saratov

440067

GSK Investigational Site, Penza

650002

GSK Investigational Site, Kemerovo

672000

GSK Investigational Site, Chita

690022

GSK Investigational Site, Vladivostok, Primorskiy Kray

C1056ABJ

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

S2000JKR

GSK Investigational Site, Rosario

C1424BSF

GSK Investigational Site, Buenos Aires

C1425BEN

GSK Investigational Site, Buenos Aires

C1426ABP

GSK Investigational Site, Buenos Aires

M5500CCG

GSK Investigational Site, Mendoza

T4000DGF

GSK Investigational Site, San Miguel de Tucumán

N-5021

GSK Investigational Site, Bergen

N-2020

GSK Investigational Site, Skedsmokorset

03680

GSK Investigational Site, Kiev

03038

GSK Investigational Site, Kyiv

03049

GSK Investigational Site, Kyiv